These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27349164)

  • 1. After the legalisation of cannabis: the Cannabis Incorporated Society (CIS) regulatory model for recreational cannabis in New Zealand.
    Wilkins C
    N Z Med J; 2016 Apr; 129(1433):74-7. PubMed ID: 27349164
    [No Abstract]   [Full Text] [Related]  

  • 2. Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA.
    Chiu V; Leung J; Hall W; Stjepanović D; Degenhardt L
    Neuropharmacology; 2021 Aug; 193():108610. PubMed ID: 34010617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 'community enterprise' model for recreational cannabis: Lessons from alcohol licensing trusts in New Zealand.
    Rychert M; Wilkins C
    Int J Drug Policy; 2019 May; 67():72-78. PubMed ID: 30959412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A "not-for-profit" regulatory model for legal recreational cannabis: Insights from the regulation of gaming machine gambling in New Zealand.
    Wilkins C
    Int J Drug Policy; 2018 Mar; 53():115-122. PubMed ID: 29346087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug legalisation.
    Farrell M
    BMJ; 2014 Aug; 349():g5233. PubMed ID: 25146248
    [No Abstract]   [Full Text] [Related]  

  • 6. Cannabis policy: issues and options.
    Abel S; Casswell S
    N Z Med J; 1998 Sep; 111(1074):367-70. PubMed ID: 11039824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Criminal justice outcomes for cannabis use offences in New Zealand, 1991-2008.
    Wilkins C; Sweetsur P
    Int J Drug Policy; 2012 Nov; 23(6):505-11. PubMed ID: 22521268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Zealand's 'Cannabis Legalisation and Regulation Bill': an evidence-based assessment and critique of essential regulatory components towards policy outcomes.
    Fischer B; Daldegan-Bueno D
    N Z Med J; 2020 Jul; 133(1519):103-111. PubMed ID: 32777801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New regulated markets for recreational cannabis: public health or private profit?
    Lenton S
    Addiction; 2014 Mar; 109(3):354-5. PubMed ID: 24524314
    [No Abstract]   [Full Text] [Related]  

  • 10. Did we have the wrong debate about Elixinolâ„¢ and medicinal cannabis?
    Rychert M; Wilkins C
    N Z Med J; 2015 Sep; 128(1421):69-70. PubMed ID: 26370760
    [No Abstract]   [Full Text] [Related]  

  • 11. Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes.
    Hall W
    Int J Drug Policy; 2017 Apr; 42():57-62. PubMed ID: 27908654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decriminalisation of recreational cannabis in South Africa.
    Parry C; Myers B; Caulkins J
    Lancet; 2019 May; 393(10183):1804-1805. PubMed ID: 31057166
    [No Abstract]   [Full Text] [Related]  

  • 13. Why did New Zealand's referendum to legalise recreational cannabis fail?
    Rychert M; Wilkins C
    Drug Alcohol Rev; 2021 Sep; 40(6):877-881. PubMed ID: 33677836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social and public health implications of the legalisation of recreational cannabis: A literature review.
    Mokwena K
    Afr J Prim Health Care Fam Med; 2019 Nov; 11(1):e1-e6. PubMed ID: 31793317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis and the criteria for legalisation of a currently prohibited recreational drug: groundwork for a debate.
    Edwards G
    Acta Psychiatr Scand Suppl; 1974; 251():1-62. PubMed ID: 4533232
    [No Abstract]   [Full Text] [Related]  

  • 16. The case for cannabis as a prescription drug.
    Coombes R
    Nurs Times; 1998 Jan 21-27; 94(3):13. PubMed ID: 9510754
    [No Abstract]   [Full Text] [Related]  

  • 17. Decriminalisation of cannabis.
    Males M
    Lancet; 1995 Dec 23-30; 346(8991-8992):1708. PubMed ID: 8551849
    [No Abstract]   [Full Text] [Related]  

  • 18. Cannabis regulation: high time for change?
    Coombes R
    BMJ; 2014 May; 348():g3382. PubMed ID: 24850823
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicinal Cannabis Scheme in New Zealand: lessons from international experience and our own recent drug policy reform setbacks.
    Rychert M; Wilkins C; Noller G
    N Z Med J; 2019 Oct; 132(1503):8-12. PubMed ID: 31581177
    [No Abstract]   [Full Text] [Related]  

  • 20. MPs back cannabis motion.
    Doult B
    Nurs Stand; 1995 Mar 22-28; 9(26):8. PubMed ID: 7537054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.